Insights into pregnancy associated and atypical hemolytic uremic syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Jokiranta

TS.

HUS and atypical HUS. Blood 2017; 129: 2847–2856.

Bruel

Kavanagh

Noris

et al . Hemolytic uremic syndrome in pregnancy and postpartum. Clin J Am Soc Nephrol 2017; 12: 1237–1247.

Shatzel

Taylor

JA.

Syndromes of thrombotic microangiopathy. Med Clin North Am 2017; 101: 395–415.

Fakhouri

Pregnancy-related thrombotic microangiopathies: clues from complement biology. Transfus Apher Sci 2016; 54: 199–202.

Dashe

Ramin

Cunningham

FG.

The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 1998; 91: 662–668.

Legendre

Licht

Muus

et al . Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013; 368: 2169–2181.

Gaggl

Aigner

Csuka

et al . Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2018; 29: 1020–1029.

Huerta

Arjona

Portoles

et al . A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome. Kidney Int 2018; 93: 450–459.